These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25804613)
21. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975 [TBL] [Abstract][Full Text] [Related]
22. [Interaction of estrogens and genetic risk factors for thrombosis]. Aiach M Therapie; 1999; 54(3):357-61. PubMed ID: 10500451 [TBL] [Abstract][Full Text] [Related]
23. JAK2 mutations across a spectrum of venous thrombosis cases. Shetty S; Kulkarni B; Pai N; Mukundan P; Kasatkar P; Ghosh K Am J Clin Pathol; 2010 Jul; 134(1):82-5. PubMed ID: 20551270 [TBL] [Abstract][Full Text] [Related]
24. Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms. Dong B; Zhang Y; Fu X; Wang G Thromb Res; 2012 May; 129(5):664-5. PubMed ID: 22197451 [No Abstract] [Full Text] [Related]
25. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975 [TBL] [Abstract][Full Text] [Related]
26. Is the JAK2 V617F mutation a hallmark for different forms of thrombosis? Zerjavic K; Zagradisnik B; Stangler Herodez S; Lokar L; Glaser Krasevac M; Kokalj Vokac N Acta Haematol; 2010; 124(1):49-56. PubMed ID: 20616539 [TBL] [Abstract][Full Text] [Related]
27. Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden. Rahimi Z; Mozafari H; Shahriari-Ahmadi A; Alimogaddam K; Ghavamzadeh A; Aznab M; Mansouri K; Rezaei M; Parsian A Blood Coagul Fibrinolysis; 2010 Jul; 21(5):385-8. PubMed ID: 20479641 [TBL] [Abstract][Full Text] [Related]
28. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis. de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the presence of hereditary and acquired thrombophilias in Brazilian children and adolescents with diagnoses of portal vein thrombosis. Ferri PM; Rodrigues Ferreira A; Fagundes ED; Xavier SG; Dias Ribeiro D; Fernandes AP; Borges KB; Liu SM; de Melo Mdo C; Roquete ML; Penna FJ J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):599-604. PubMed ID: 22684349 [TBL] [Abstract][Full Text] [Related]
30. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664 [TBL] [Abstract][Full Text] [Related]
31. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848 [TBL] [Abstract][Full Text] [Related]
33. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Linnemann B; Meister F; Schwonberg J; Schindewolf M; Zgouras D; Lindhoff-Last E; Thromb Haemost; 2008 Sep; 100(3):440-6. PubMed ID: 18766260 [TBL] [Abstract][Full Text] [Related]
34. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665 [TBL] [Abstract][Full Text] [Related]
35. Thrombophilia in Klinefelter Syndrome With Deep Venous Thrombosis, Pulmonary Embolism, and Mesenteric Artery Thrombosis on Testosterone Therapy: A Pilot Study. Glueck CJ; Jetty V; Goldenberg N; Shah P; Wang P Clin Appl Thromb Hemost; 2017 Nov; 23(8):973-979. PubMed ID: 27582022 [TBL] [Abstract][Full Text] [Related]
36. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Arsov T; Miladinova D; Spiroski M Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522 [TBL] [Abstract][Full Text] [Related]
37. Minor events and the risk of deep venous thrombosis. Eekhoff EM; Rosendaal FR; Vandenbroucke JP Thromb Haemost; 2000 Mar; 83(3):408-11. PubMed ID: 10744145 [TBL] [Abstract][Full Text] [Related]
38. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778 [TBL] [Abstract][Full Text] [Related]
39. Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders. De T; Prabhakar P; Nagaraja D; Christopher R J Neurol Sci; 2012 Dec; 323(1-2):178-82. PubMed ID: 23031663 [TBL] [Abstract][Full Text] [Related]
40. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies. Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]